Phototherapy is an effective treatment strategy for a variety of sclerosing skin conditions.
There are a number of phototherapeutic modalities used for the treatment of sclerosing skin …

Systemic and localized scleroderma are difficult to manage diseases with no accepted gold
standard of therapy to date. Phototherapeutic modalities for scleroderma show promise. A …

The treatment of sclerosing skin diseases [systemic sclerosis, localized scleroderma, lichen
sclerosus et atrophicus, sclerodermoid graft‐vs.‐host disease, scleredema adultorum …

BACKGROUND: Ultraviolet (UV) A-1 phototherapy is now available for a variety of skin
diseases. Increasingly since 1995, there have been investigations of the efficacy of UVA-1 …

Sclerosing skin diseases such as localized scleroderma or lichen sclerosus frequently result
in significant morbidity that requires treatment. Until 10 years ago, no generally effective …

Systemic scleroderma—also known as systemic sclerosis (SS c)—is a chronic systemic
connective tissue disease characterized by collagen deposition in cutaneous and internal …

In systemic sclerosis (SSc; scleroderma) fibrosis of the skin can lead to considerable
morbidity. No significant improvement has been reported from studies investigating …

Summary Background/Purpose Ultraviolet A1 (UVA 1) phototherapy has been used for over
15 years in the United States, primarily for the treatment of localized sclerosis and various …

Scleroderma is a chronic disease of connective tissue characterized by deposition of large
amounts of collagen. Localized scleroderma affects only the skin, whereas systemic …

Photochemotherapy for systemic and localized scleroderma - ScienceDirect Skip to main
contentSkip to article Elsevier logo Journals & Books Search RegisterSign in View PDF Download …